A detailed history of Pale Fire Capital Se transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Pale Fire Capital Se holds 510,724 shares of RAPT stock, worth $418,793. This represents 0.16% of its overall portfolio holdings.

Number of Shares
510,724
Previous 16,070 3078.12%
Holding current value
$418,793
Previous $49 Million 1994.41%
% of portfolio
0.16%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.76 - $3.75 $870,591 - $1.85 Million
494,654 Added 3078.12%
510,724 $1.03 Billion
Q2 2024

Aug 13, 2024

BUY
$2.89 - $9.38 $46,442 - $150,736
16,070 New
16,070 $49 Million

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $24.3M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.